George Elston

CIK 1429932 · Chief Financial Officer · last filed 2026-05-27

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$1.59M

Companies

4

Total Filings

35

Lifetime Open-Market Net

$40.3K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
EYPT Chief Financial Officer 121,691 $13.03 $1.59M $34.8K 24 2026-05-27
JUNIPER PHARMACEUTICALS INC (JNP) Delisted Chief Financial Officer 1,000 $5.5K 2 2016-08-31
JUNIPER PHARMACEUTICALS INC (CBRX) Delisted Chief Financial Officer $0 1 2014-10-03
Celldex Therapeutics, Inc. (AVAN) Delisted Director $10.04 $0 1 2008-09-29

Recent Filings · Page 2 of 4

35 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2024-02-13 EYPT Mixed +7,608 -$91.9K EDGAR
2024-01-09 EYPT Mixed +10,374 -$100.2K EDGAR
2023-10-17 EYPT Grant (A) $0 EDGAR
2023-06-22 EYPT Grant (A) $0 EDGAR
2023-05-30 EYPT Grant (A) $0 EDGAR
2023-02-13 EYPT Exer (M) +10,800 $0 EDGAR
2023-01-10 EYPT Grant (A) $0 EDGAR
2022-02-11 EYPT Mixed +3,245 -$17.4K EDGAR
2021-06-23 EYPT Grant (A) $0 EDGAR
2020-09-09 EYPT Buy (P) +10,000 $4.8K EDGAR
Showing 1120 of 35
Page 2 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.